STING1 and neoplasm: In vitro, IFN-β production and DC activation are triggered by tumor cell-derived DNA, via cyclic-GMP-AMP Synthase (cGAS), Stimulator of interferon genes (STING) and Interferon Regulatory Factor 3 (IRF3) (Figure 2).